Navigation Links Issues Report on Prostate Health Claim Lawsuits and Propecia Side Effect Litigation

Santa Cruz, CA (PRWEB) June 22, 2012

Since last year's FDA announcement regarding the labeling change for Propecia (finasteride), additional Propecia lawsuits have been filed, and subsequently consolidated into a Multi-District Litigation (MDL). The Propecia label was updated in June, 2011 to add "Increased Risk of High-Grade Prostate Cancer with 5-Alpha Reductase Inhibitors" to the drug's risk profile.

Such warnings regarding drug side effects can prompt patients to become more aware of their health in general. But as health-conscious men have become a flourishing target audience for marketers, some of the ads targeting these men have begun to become targets themselves--for false advertising lawsuits.

Most recently, the prostate health claims, subsequently deemed false advertising, by POM Wonderful, which claimed at one point that their pomegranate juice could help prevent heart disease, prostate cancer and even impotence, came under the scrutiny of the Federal Trade Commission (FTC). The FTC filed a false advertising complaint against POM Wonderful LLC (FTC File No. 082-3122, Docket No. 9344 ), and a consumer fraud class action lawsuit has been filed (W. Rex Templeton, Jr. v. POM Wonderful, LLC and Roll International Corporation, Case No. 12-cv-53, U.S. District Court, Southern District of Georgia, Savannah Division).

After administrative Judge D. Michael Chappell ruled on the FTC complaint that POM juice claims had been exaggerated, the company quickly responded with a new ad campaign. The new ads, however, as The New York Times reported in "Pom Uses Ad to Answer Judge’s Order" (5/25/12), included selective quotes taken out of context from the judge's ruling. According to the Times, "Those aspects of the judge’s ruling are not mentioned in Pom Wonderful’s new ads, however. Rather, the ads use flattering phrases plucked from the ruling to recommend the health benefits of pomegranate juice and invited readers to “be the judge.”

In 2010, Bayer AG was made to pay a $3.3 million false advertising settlement over claims that its One-A-Day® Men's Health Formula vitamins had the potential to cure, treat or prevent any disease including cancer (McKinney v. Bayer Corporation et al, Case No.1:10-CV-224, U.S. District Court, Northern District of Ohio,). Bayer couldn't produce scientific evidence to back such claims and a settlement was reached with attorneys general from three states.

Propecia was originally approved by the FDA to treat an enlarged prostate but has now had its label changed by the FDA to reflect its potential link to high-grade Propecia prostate cancer. Additionally, in April 2012, the FDA again revised Propecia (Finasteride) labelling to expand the list of sexual adverse events allegedly linked to the drug.

According to a study conducted by Michael S. Irwig, M.D., assistant professor of medicine, division of endocrinology, medical faculty associates, George Washington University and published in The Journal of Sexual Medicine (Volume 8, Issue 6, June, 2011), 70 percent of male participants who took finasteride had problems with orgasm and 94 percent presented with low sexual desire. "And it turns out that almost all of these men had multiple sexual dysfunction problems," Dr. Irwig notes. While Dr. Irwig can't quantify the risk, he maintains, "it's pretty clear there is a relationship here."

The issue has led to Propecia lawsuits--and now, after a consolidated complaint regarding Propecia was filed in St. Louis Circuit Court (case no. 2012-12222-CC00463), Propecia lawsuits have been consolidated into a Multi-District Litigation in the U.S. District Court for the Eastern District of New York (MDL Docket No. 2331). For Propecia victims, remains an ongoing resource for legal news and information related to Propecia side effects.

About provides comprehensive legal news and critical information for those affected by once-in-a-lifetime situations involving medical device lawsuits, personal injury, defective products, California Overtime and labor issues or a host of others. Readers seeking legal help can request it by completing a form which is distributed to attorneys specializing in these cases. Trial attorneys utilize the site to keep abreast of hot legal issues and settlements as well as connect with potential clients.

About Online Legal Media

Online Legal Media owns and operates websites providing information for the general public and the legal community., founded in 2001, is an online legal news publication with over 2.1 million visitors annually and hundreds of thousands of requests for attorney help from its readership. serves as a portal for trial attorneys to network and to market their firms to other attorneys and legal professionals. offers up-to-date resources and news for those suffering from asbestos exposure and mesothelioma. Online Legal Media is based in Santa Cruz, California.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. UCSF chancellor issues call-to-arms to patient advocates
2. Radiologists rank themselves as less than competent on health policy issues
3. Genetic abnormalities in benign or malignant tissues predict relapse of prostate cancer
4. FDA Issues Multiple Sclerosis Drug Alert
5. Quality of care, other issues may cause worse results in black prostate cancer surgery patients
6. U.S. Task Force Issues Blood Pressure Guidelines
7. Internists in Washington to discuss patient and professional issues in meetings on Capitol Hill
8. Cheaper drug could lead to serious eye issues
9. Insulite Labs announces the launch of the PCOS Inspiration Hour, a one hour virtual gathering place for women with PCOS and other women’s health issues to come together.
10. Young girls more likely to report side effects after HPV vaccine
11. Preteens More Likely to Report HPV Vaccine Side Effects
Post Your Comments:
(Date:11/25/2015)... Los Angeles, CA (PRWEB) , ... November 25, 2015 , ... ... advanced da Vinci surgical robot is being more and more widely heralded as a ... robotic assisted da Vinci method has over traditional laparoscopic surgery is that it can ...
(Date:11/25/2015)... IL (PRWEB) , ... November 25, 2015 , ... The ... announce a recent successful appellate decision obtained by Attorneys Francisco J. Botto and Alex ... Adcock v. Illinois Workers’ Compensation Comm’n, 2015 IL App (2d) 130884WC. , According to ...
(Date:11/25/2015)... ... 25, 2015 , ... Brillianteen, McGaw YMCA’s student-produced musical show, ... 65th Anniversary Brillianteen Revue, scheduled for March 4-6, 2016. Auditions for this final ... has been a treasured tradition for numerous families in the Evanston community. Over ...
(Date:11/25/2015)... Spring, Md (PRWEB) , ... November 25, 2015 ... ... Pulmonary Hypertension Association (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible ... history of this disease. The Periwinkle Pioneers, nominated by the public, will receive ...
(Date:11/25/2015)... ... 25, 2015 , ... Bcureful—a non-profit organization devoted to advancing ... public awareness of the disorder while helping to bring expert medical care and ... bolster progress at the Tuberous Sclerosis Complex Center at Ann & Robert H. ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... Frankreich, November 25, 2015 ... dass sie eine Lizenz für das Patent über eine ... UCBL und ENS-Lyon innehaben, an Enyo Pharma vergeben haben. ... AAP8 ins Leben gerufenen und von Edelris gemeinsam mit ... als ein Behandlungsziel für HBV identifiziert, und es wurden ...
(Date:11/24/2015)... The hope of bearing a ... IVF cycles. After failure of over 15 IVF cycles, ... all hopes that she would be able to conceive ever. But finally optimism prevailed as ... failure of over 15 IVF cycles. ... take one last attempt with Gaudium IVF Center in ...
(Date:11/24/2015)... 2015  Thanks to a donor with a personal ... Center,s Sister Diane Grassilli Center for Women,s Health now ... San Francisco . Fred ... with a gift of $617,320 that allowed the Center ... Tomosynthesis and Whole Breast Ultrasound. Tomosynthesis, three-dimensional (3-D) mammography ...
Breaking Medicine Technology: